Within a two-week span, two maintenance workers at the Readville bus yard were diagnosed with COVID-19, according to Transdev, the private contractor that oversees the citys three school bus yards.
As more teachers test positive for COVID-19, city officials are refusing to disclose how many other school staffers have been quarantined because of exposure to those infected.
Fascinating insights and personal stories make this a compelling read.
Himani Shivpuri, who was tested positive for coronavirus, has been discharged from hospital and advised to be in home quarantine.
The student centre, as well as several other facilities, will be closed for the next two weeks, according to the student union.
Visiting Lazaretto Nuovo, the quarantine island where today's anti-contagion practices began, feels more timely than ever.
The coronavirus pandemic has brought countries to a standstill. In many places, as countries reopen, Covid-19 cases are on the rise. Follow here for the latest.
The virus isnt going away, but a vaccine is coming and so is an election.
Counsel assisting inquiry into bungled program says risks could have been foreseen with appropriate focus on health
Both human history and experience with Operation Outbreak, an educational platform that simulates disease spread, had shown its inventors that people behave predictably under the threat of a virulent pathogen.
We look at the strategies available to authorities and how effective they appear to be
A cyber attack on a German hospital is being blamed for the loss of a human life.
Key proteins used by coronavirus for its reproduction being modeled on NSF-funded Frontera supercomputer by Andres Cisneros research group of the University of North Texas. Research goals include finding ways to improve on COVID-19 therapeutic remdesivir. NSF-funded Frontera allocation awarded to Cisneros through the COVID-19 High Performance Computing Consortium.
The career of the coronavirus so far is, in Darwinian terms, a great success story.
Researchers recently isolated a molecule that could help create a drug capable of neutralizing the coronavirus. Clinical trials involving the drug are set to begin on humans next year. Even if a coronavirus vaccine is approved later this year, it may only work 50% of the time.
The hypothesis could help guide new prevention methods and treatment for Covid-19.
/PRNewswire/ -- The "Cytogenetics - Technologies, Markets & Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering. This...
/PRNewswire/ -- An experimental compound prevents the virus that causes COVID-19 from entering human airway cells, a new study finds. Posted online recently on...
Drugs are being tested that could reduce symptoms and save lives. But, given the way drugs are developed, it's unlikely that any single medicine will be anywhere as potent as a successful vaccine.
Scientists have used a new high-speed, <em
The removal of one gene renders poxvirusesa lethal family of viral infections that are known to spread from animals to humansharmless, a new study in the journal Science Advances reports.
A new study, compounded with recent reports of reinfection, shows why building immunity to Covid-19 is trickier than we'd like to believe.
"We thought that the molecule would decrease inflammation, but we were surprised to see that it could provide more protection at the same time."
Wearing face masks may allow a tiny number of viral particles to slip through, possibly allowing our body to gain some sort of immunity.
The results of the phase 3 CheckMate 9ER trial have provided a new first-line treatment option for patients with metastatic kidney cancer. The late breaking results are presented at ESMO 2020.
Immunomedics Inc's cancer drug Trodelvy, which received accelerated U.S. regulatory approval in April, extended survival time in previously treated patients with an advanced form of breast cancer in a clinical trial, the company said on Saturday.
Earlier this month, the SII had paused the clinical trials of the vaccine candidate in the country.
/PRNewswire/ -- BioEclipse Therapeutics, a private clinical-stage biopharmaceutical company developing first-in-class, curative immuno-oncology therapeutics,...
Guru's firm increases stake in clinical-stage biotech
/PRNewswire/ -- Sumitomo Dainippon Pharma Oncology, Inc., a developer of novel cancer therapeutics, today presented new data from the ongoing Phase 1 study...
/PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today announced updated clinical results from its Phase 2...
/PRNewswire/ -- Medimetriks Pharmaceuticals, Inc. today announced that the Company received a Type C Meeting Written Response from the U.S. Food and Drug...
/PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) and Incyte (NASDAQ:INCY) announced today that the European Medicines Agency's (EMA) Committee for Medicinal...
/PRNewswire/ -- BrainCool AB, a Swedish medical device innovator, and a world leader in medical cooling technology for therapeutic hypothermia (brain cooling)...
There is some renewed hope for rheumatoid arthritis drugs like Eli Lillys Olumiant and Roches Actemra as possible COVID-19 treatments after a series of...
Roche <ROG.S> shares closed higher on Friday after the Swiss drugmaker said a study had shown its drug Actemra helped against COVID-19 and announced the release of a new antibody test as well as a European recommendation for a liver cancer cocktail.
Breakthrough in gene editing should allow scientists to answer key questions in biology. A team at the Marine Biological Laboratory (MBL) has achieved the first gene knockout in a cephalopod using the squid Doryteuthis pealeii, an exceptionally important research organism in biology for nearly a
Addressing concerns about gene drive releases in the wild, UC San Diego scientists and their colleagues have developed two new genetic systems that halt or eliminate gene drives after release. Created in fruit flies, the e-CHACRs and ERACRs are powerful gene drive control mechanisms that were meticulously developed and tested at the genetic and molecular levels.
In the past decade, researchers have engineered an array of new tools that control the balance of genetic inheritance. Based on CRISPR technology, such gene drives are poised to move from the laboratory into the wild where they are being engineered to suppress devastating diseases such as mosquito-borne malaria, dengue, Zika, chikungunya, yellow fever and West Nile. Gene drives carry the power to immunize mosquitoes against malarial parasites, or act as genetic insecticides that reduce mosquito
Jennifer Doudna, one of the pioneers of the gene-editing technique known as CRISPR, thinks the biotech tool could be an essential one for combating COVID-19 and future pandemics. Due to its capacity to be “reprogrammed” like software, CRISPR could eventually be integral to countless tests and treatments. In an interview at Disrupt 2020, Doudna was […]
Stripe rust is one of the most destructive wheat diseases in the world, especially in the United States. While the disease can be controlled by chemicals, those may be harmful to humans, animals, and the environment and the application can cost millions of dollars to wheat production. Rather than use chemicals, many farmers would prefer to grow wheat varieties that resist stripe rust and the development of such varieties is a top priority for wheat breeding programs.
Designer babies, mutant mozzies and frankenfoods: These are the images that often spring to mind when people think of genome editing.
A CRISPR-based diagnostic for the SARS-Cov-2 virus can produce results in less than an hour with similar accuracy as the standard PCR test now used. Development of the Covid-19 test was led by researchers at MIT and the Broad Institute of MIT and Harvard.
Stripe rust is one of the most destructive wheat diseases in the world, especially in the United States. While the disease can be controlled by chemicals, those may be harmful to humans, animals, and the environment and the application can cost millions of dollars. Rather than use chemicals, many farmers would prefer to grow wheat varieties that resist stripe rust and the development of such varieties is a top priority for wheat breeding programs.
The largest ever survey on global public attitudes towards genomic research and data sharing suggests that work is needed to raise levels of public trust in how genetic data is used in order for that data to fulfil its promise to advance human health and medicine.
An international team of plant scientists have shown the potential to rapidly improve the quality of barley grain through a genetic tool known as CRISPR or gene editing.
The technique could improve livestock resilience against disease and enhance food production in an increasingly demanding world.
Researchers from the? Masonic Medical Research Institute (MMRI), the Precision Cardiology Lab (PCL) of the Broad Institute at MIT and Harvard, Bayer USA, Massachusetts General Hospital, and University of Pennsylvania collaborated to uncover some pressing questions about the biology of the heart. While understanding the mechanisms causal to human heart disease remain active areas of research for many scientists, important knowledge gaps about its composition and function remain unknown.
An unexpected discovery could provide stem cells for the creation of placenta tissue. Until now, that hasn't been possible.
The stem cells tasked with creating and maintaining biological tissues have a difficult job. They have to precisely divide to form new specialized cells, which are destined to different fates even though they contain identical DNA. An obvious question then is: How do the cells divide in all the right ways to produce a healthy tissue? This was the grand motivating question for Andrew Muroyama, a postdoctoral scholar in the lab of Stanford University biologist Dominique Bergmann, as he monitored d
Scientists from the RIKEN Center for Biosystems Dynamics Research, European Molecular Biology Laboratory (EMBL) Barcelona, Universitat Pompeu Fabra, and Kyoto University have found that the 'segmentation clock'a genetic network that governs the body pattern formation of embryosprogresses more slowly in humans than in mice because the biochemical reactions are slower in human cells. The differences in the speeds of biochemical reactions may underlie differences between species in the tempo of dev
/PRNewswire/ -- AllCells, the leading provider of primary cells supporting biomedical research and commercialization of pharmacological and cellular therapies,...
In research recently published in Stem Cell Reports, Andrejs Ivanovs, Alexander Medvinsky (firstname.lastname@example.org) and colleagues from the University of Edinburgh discovered that HSCs from early human embryos, when HSCs are just starting to form, are more robust at expanding than those from the cord blood.
Ling Gao and colleagues have developed a strategy that uses exosomes - tiny membrane-bound sacs secreted by cells - to mimic the heart-regenerating effects of cardiac cell transplants, while potentially avoiding risks associated with whole-cell transplants.
An international collaboration involving Duke-NUS Medical School and Monash University researchers has made an unexpected world-first stem cell discovery that may lead to new treatments for placenta complications during pregnancy.
Researchers from Tokyo Medical and Dental University (TMDU) engineered three-dimensional functional heart organoids resembling the developing heart. By exposing mouse embryonic stem cells to two key proteins during heart development, the researchers were able to form heart organoids with structural, functional, and molecular similarities to the embryonic heart during development. This method could be used to study heart development and to screen for novel drugs against heart disease.
Our cells may be small, but they are mighty. And they are made of lots of amazing stuff, from the DNA that tells your body how to grow, to mini skeletons that let cells move around.
The study published in Cell shows that macrophages, a type of immune cell, help cardiac cells to get rid of their waste material, and that this maintains the metabolic and contractile properties of the heart.
CardioClusters use three types of cells to reduce scar tissue and improve function by integrating into and persisting within damaged heart tissue.